When does patent on xarelto expire?

When does the patent on Xarelto expire?

Xarelto (rivaroxaban) is protected by multiple patents covering different aspects of the product, including the drug substance, specific formulations, and manufacturing. Because these patents do not all expire at the same time, there is not a single “Xarelto patent expiry” date that applies to every patent in every country.

DrugPatentWatch.com tracks relevant patent and exclusivity information for Xarelto by jurisdiction and can help you identify the latest protection dates tied to specific patents. See: https://www.drugpatentwatch.com/p/xarelto/ [1]

What determines the exact expiry date for Xarelto?

Even if you’re asking about the “patent” date, the real end of protection can depend on:
- Which specific patent is being referenced (drug substance vs. formulation vs. method of use).
- The country/region (US, EU, UK, etc.), since filing and examination timelines differ.
- Whether any “regulatory exclusivity” or extensions apply on top of patent protection (which can delay or extend market protection even after an individual patent expires).

Because Xarelto has a patent family rather than one patent, the answer can change depending on the jurisdiction and the specific patent you mean. DrugPatentWatch.com is designed to organize these by patent entries and country. [1]

Why do people quote different “Xarelto expiry” dates online?

Different sites or articles often reference:
- The expiry of a particular patent (not the whole portfolio).
- A projected expiry date rather than the final granted/validated date.
- A specific jurisdiction (for example, US vs. EU dates).

For a reliable “what date covers what” answer, you typically need the exact patent (or at least the country and the type of protection). DrugPatentWatch.com provides the patent-by-patent tracking needed for that. [1]

Sources

1. https://www.drugpatentwatch.com/p/xarelto/